Projection-specific dopamine neurons in the ventral tegmental area participated in morphine-induced hyperalgesia and anti-nociceptive tolerance in male mice

• Published in: Journal of psychopharmacology (Oxford) Vol. 35; no. 5; p. 591
• Main Authors: Sun, Guo-Lin, Song, Zhi-Jing, Peng, Xiao-Han, Chen, Pan-Pan, Song, Ying, Qin, Xia, Hua, Rong, Zhang, Yong-Mei
• Format: Journal Article
• Language: English
• Published: United States 01.05.2021
• Subjects: Analgesics, Opioid - administration & dosage; Analgesics, Opioid - pharmacology; Analgesics, Opioid - toxicity; Animals; Dopaminergic Neurons - drug effects; Drug Tolerance; Hyperalgesia - chemically induced; Male; Mice; Mice, Inbred C57BL; Morphine - administration & dosage; Morphine - pharmacology; Morphine - toxicity; Nucleus Accumbens - drug effects; Prefrontal Cortex - drug effects; Proto-Oncogene Proteins c-fos - metabolism; Ventral Tegmental Area - drug effects; Ventral Tegmental Area - metabolism; DA neurons; anti-nociceptive tolerance; medial prefrontal cortex; nucleus accumbens; ventral tegmental area; Morphine-induced hyperalgesia
• DOI: 10.1177/0269881120985183

Long-term morphine use is associated with serious side effects, such as morphine-induced hyperalgesia and analgesic tolerance. Previous investigations have documented the association between dopamine (DA) neurons in the ventral tegmental area (VTA) and pain. However, whether VTA DA neurons are implicated in morphine-induced hyperalgesia and analgesic tolerance remains elusive. Initially, we observed behavioural effects of lidocaine administration into VTA or ablation of VTA DA neurons on morphine-induced hyperalgesia and anti-nociceptive tolerance. Subsequently, c-Fos expression in nucleus accumbens (NAc) shell-projecting and medial prefrontal cortex (mPFC)-projecting VTA DA neurons after chronic morphine treatment was respectively investigated. Afterwards, the effects of chemogenetic manipulation of NAc shell-projecting or mPFC-projecting DA neurons on morphine-induced hyperalgesia and anti-nociceptive tolerance were observed. Additionally, effects of chemogenetic manipulation of VTA GABA neurons on c-Fos expression in VTA DA neurons were investigated. Lidocaine injection into VTA relieved established hyperalgesia and anti-nociceptive tolerance whereas ablation of VTA DA neurons prevented the development of morphine-induced hyperalgesia and anti-nociceptive tolerance. Chronic morphine treatment increased c-Fos expression in NAc shell-projecting DA neurons, rather than in mPFC-projecting DA neurons. Chemogenetic manipulation of NAc shell-projecting DA neurons had influence on morphine-induced hyperalgesia and tolerance. However, chemogenetic manipulation of mPFC-projecting DA neurons had no significant effects on morphine-induced hyperalgesia and anti-nociceptive tolerance. Chemogenetic manipulation of VTA GABA neurons affected the c-Fos expression in VTA DA neurons. These findings revealed the involvement of NAc shell-projecting VTA DA neurons in morphine-induced hyperalgesia and anti-nociceptive tolerance, and may shed new light on the clinical management of morphine-induced hyperalgesia and analgesic tolerance. This study demonstrated that NAc shell-projecting DA neurons rather than mPFC-projecting DA neurons in the VTA were implicated in morphine-induced hyperalgesia and anti-nociceptive tolerance. Our findings may pave the way for the discovery of novel therapies for morphine-induced hyperalgesia and analgesic tolerance.